Aristolochia Renal Disease Link Reported In Two U.S. Cases
This article was originally published in The Tan Sheet
Executive Summary
Aristolochic acid-containing botanicals were used by two individuals in the U.S. who developed end-stage renal disease, FDA reports in an April 4 letter urging health professionals to more closely monitor their patients' dietary supplement intake.